These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 11394826)

  • 1. Safety profile of repeated infusion of platelet-like nanoparticles in healthy dogs.
    Guillaumin J; Satchell PW; Yaxley PE; Bruckman MA; Sen Gupta A
    Am J Vet Res; 2022 Jul; 83(10):. PubMed ID: 35895758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous vitamin K1 injections: dangerous prophylaxis.
    O'Reilly RA; Kearns P
    Arch Intern Med; 1995 Oct; 155(19):2127-8. PubMed ID: 7575074
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of diphacinone rodenticide toxicosis in the dog and its therapeutic implications.
    Mount ME; Feldman BF
    Am J Vet Res; 1983 Nov; 44(11):2009-17. PubMed ID: 6689111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
    Fan J; Armitstead JA; Adams AG; Davis GA
    Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of a long-acting anticoagulant rodenticide poisoning cohort with vitamin K1 during the maintenance period.
    Long J; Peng X; Luo Y; Sun Y; Lin G; Wang Y; Qiu Z
    Medicine (Baltimore); 2016 Dec; 95(51):e5461. PubMed ID: 28002326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practitioner report involving intravenous use of vitamin K1 prompts label review and revision.
    Burgess TM; Meyer EK; Bataller N
    J Am Vet Med Assoc; 2001 Jun; 218(11):1767-70. PubMed ID: 11394826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cutaneous hypersensitivity at the site of injection of vitamin K1].
    Moreau-Cabarrot A; Giordano-Labadie F; Bazex J
    Ann Dermatol Venereol; 1996; 123(3):177-9. PubMed ID: 8761778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and therapy of anticoagulant rodenticide intoxications.
    Mount ME
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):115-30. PubMed ID: 3282375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vitamin K1: an option to reduce warfarin's activity.
    Harrell CC; Kline SS
    Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management.
    King N; Tran MH
    Transfus Med Rev; 2015 Oct; 29(4):250-8. PubMed ID: 26239439
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.